Clinical Report: Precision Therapies: The Last Mile

Overview

This report highlights the critical delays in patient diagnosis that hinder the timely delivery of precision therapies. It emphasizes the disconnect between patient journeys and physician engagement, particularly in the context of rare diseases and targeted treatments.

Background

Timely diagnosis is essential for the effective application of precision therapies, yet many patients experience significant delays in receiving appropriate diagnoses. This issue is particularly pronounced in rare diseases and complex conditions, where misdiagnosis or prolonged diagnostic odysseys can lead to missed treatment opportunities. Understanding and addressing these delays is crucial for improving patient outcomes and ensuring that innovative therapies reach those who need them most.

Data Highlights

No numerical data presented in the source material.

Key Findings

• Delays in diagnosis can extend to years, particularly for rare diseases and complex conditions.
• The current commercial model primarily targets physicians, neglecting the patient journey prior to diagnosis.
• Precision medicine requires a shift in focus from broad physician engagement to understanding patient pathways.
• Existing data sources, such as claims records and referral patterns, can help illuminate patient journeys but are often underutilized.
• Systematic changes in testing workflows are necessary to align scientific advancements with clinical practice.

Clinical Implications

Healthcare professionals must recognize the importance of timely diagnosis in the context of precision therapies. By understanding the patient journey and advocating for improved diagnostic processes, clinicians can help bridge the gap between therapy development and patient access.

Conclusion

Addressing the last mile problem in diagnosis is essential for maximizing the benefits of precision therapies. A collaborative approach that integrates clinical and commercial insights may enhance patient outcomes and reduce diagnostic delays.

References

1. Atlantic Health System, Clinician Resources, 2023 -- Precision Oncology in Practice: How Theranostics Personalizes Treatment
2. The ASCO Post, 2022 -- Going the Last Mile: Accelerating Delivery of Multiple Myeloma Therapies to All Patients
3. Ophthalmology Management, 2026 -- Adding Interventional DED Treatment to Your Practice
4. ASCO Updates Multiple Lung Cancer Guidelines, 2024 -- ASCO Updates Multiple Lung Cancer Guidelines
5. phoenix children's medical connection — Enhancing Precision in Pediatric Neurosurgery: Advanced Robotics Integration with LITT
6. ASCO Updates Multiple Lung Cancer Guidelines
7. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®)
8. GeneDx Announces American Academy of Pediatrics Recommends Exome and Genome Sequencing as First-Tier Tests for Children with Global Developmental Delay or Intellectual Disability | GeneDx, LLC